Company / Current Assets
CG Oncology, Inc. Current Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$759.5M
FY2025
5-year range
$194.1M / $759.5M
FY2023-FY2025
Trend
+0.7%
vs FY2024
Sector context
#74 of 213
Health Care
What the data says
At $759M, CG Oncology, Inc.'s current assets ranks #74 of 213 in the Health Care sector. Improved from $194M to $759M over the past 2 years.
Based on SEC 10-K filings.
$759M in FY2025.
Improved from $194M to $759M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#74 of 213 in Health CareTop 35% of 213This company $759.5M Sector average $2.5B
▼
-69.9% below sector average
Key checks
Key Insights
- In FY2025, current assets increased 0.7% year-over-year.
- Ranks #74 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $759.5M | +0.7% |
| FY2024 | $754.2M | +288.5% |
| FY2023 | $194.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026